These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38091700)

  • 1. The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report.
    Findlay MC; Sabahi M; Azab M; Drexler R; Rotermund R; Ricklefs FL; Flitsch J; Smith TR; Kilgallon JL; Honegger J; Nasi-Kordhishti I; Gardner PA; Gersey ZC; Abdallah HM; Jane JA; Knappe UJ; Uksul N; Schroder HWS; Eördögh M; Losa M; Mortini P; Gerlach R; Antunes ACM; Couldwell WT; Budohoski KP; Rennert RC; Karsy M
    Clin Neurol Neurosurg; 2024 Jan; 236():108079. PubMed ID: 38091700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combination of Dopamine Agonist Treatment and Surgery May Be the Best Option in Challenging Prolactinoma Cases: A Single-Centre Experience.
    Demir D; Demir AN; Sulu C; Zulfaliyeva G; Cetintas SC; Ozkaya HM; Kadioglu P; Gazioglu N; Tanriover N
    World Neurosurg; 2023 Jul; 175():e1166-e1174. PubMed ID: 37120141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists.
    Park K; Park KH; Park HR; Lee JM; Kim YH; Kim DY; Won TB; Kong SH; Kim JH; Shin CS; Paek SH
    J Korean Med Sci; 2021 Apr; 36(15):e97. PubMed ID: 33876586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.
    Andereggen L; Frey J; Andres RH; Luedi MM; El-Koussy M; Widmer HR; Beck J; Mariani L; Seiler RW; Christ E
    J Endocrinol Invest; 2021 Dec; 44(12):2621-2633. PubMed ID: 33847973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus.
    Abou-Al-Shaar H; Mallela AN; Patel A; Shariff RK; Shin SS; Choi PA; Faraji AH; Fazeli PK; Costacou T; Wang EW; Fernandez-Miranda JC; Snyderman CH; Gardner PA; Zenonos GA
    Pituitary; 2022 Jun; 25(3):508-519. PubMed ID: 35467273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
    Hamilton DK; Vance ML; Boulos PT; Laws ER
    Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients.
    Ottenhausen M; Conrad J; Wolters LM; Ringel F
    Neurosurg Rev; 2023 May; 46(1):128. PubMed ID: 37249700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
    Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E
    Endocrine; 2017 Jan; 55(1):223-230. PubMed ID: 27688009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
    Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.
    Hong JW; Lee MK; Kim SH; Lee EJ
    Endocrine; 2010 Feb; 37(1):140-7. PubMed ID: 20963563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transsphenoidal microsurgical results of female patients with prolactinomas.
    Ikeda H; Watanabe K; Tominaga T; Yoshimoto T
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1621-5. PubMed ID: 23498159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution.
    Dallapiazza R; Bond AE; Grober Y; Louis RG; Payne SC; Oldfield EH; Jane JA
    J Neurosurg; 2014 Sep; 121(3):511-7. PubMed ID: 24995783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Endoscopic Transsphenoidal Resection for Prolactinoma: A Retrospective Multicenter Case-series.
    Zandbergen IM; Huntoon KM; White TG; Bakker LEH; Verstegen MJT; Ghalib LM; van Furth WR; Pelsma ICM; Dehdashti AR; Biermasz NR; Prevedello DM
    Arch Med Res; 2023 Dec; 54(8):102919. PubMed ID: 38040527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP.
    Donegan D; Atkinson JL; Jentoft M; Natt N; Nippoldt TB; Erickson B; Meyer F; Erickson D
    Endocr Pract; 2017 Jan; 23(1):37-45. PubMed ID: 27682355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selection of management tactics in treatment of giant prolactin-secreting pituitary adenomas].
    Astaf'eva LI; Kadashev BA; Kalinin PL; Kutin MA; Faĭzullaev RB; Sidneva IuG; Tenedieva VD; Tropinskaia OF
    Zh Vopr Neirokhir Im N N Burdenko; 2009; (2):23-8; discussion 28-9. PubMed ID: 19569545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
    Primeau V; Raftopoulos C; Maiter D
    Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
    Wu ZB; Su ZP; Wu JS; Zheng WM; Zhuge QC; Zhong M
    Pituitary; 2008; 11(1):63-70. PubMed ID: 17917811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Leksell gamma knife in the treatment of prolactinoma patients.
    Jezková J; Hána V; Krsek M; Weiss V; Vladyka V; Liscák R; Vymazal J; Pecen L; Marek J
    Clin Endocrinol (Oxf); 2009 May; 70(5):732-41. PubMed ID: 18710463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of prolactinomas: should dopamine agonist treatment be life-long?
    Guitelman M
    Front Horm Res; 2006; 35():88-101. PubMed ID: 16809925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.